IONTAS and Adaptate Biotherapeutics collaborate to identify optimised antibodies for novel cancer targets
IONTAS Limited (IONTAS), a leader in the discovery and optimisation of fully human antibodies, today announced it has entered into a collaboration agreement with Ada...


